← back to search

Jillian A. Hung

Westmead Institute for Medical Research · AU
Area of research
Cancer Research · Reproductive Medicine
Research interest
Research interests include Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, and Genetic factors in colorectal cancer.
h-index
35
citations
19,375
works
94
NIH funding
primary concept
Biology
email

Recent publications

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Molecular Cancer 2024cited by 27position: middledoi
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Nature Genetics 2022cited by 109position: middledoi
Prognostic gene expression signature for high-grade serous ovarian cancer
Annals of Oncology 2020cited by 172position: middledoi
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Modern Pathology 2020cited by 41position: middledoi
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Nature Communications 2018cited by 288position: middledoi
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
Mayo Clinic Proceedings 2018cited by 30position: middledoi
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
JAMA Oncology 2017cited by 398position: middledoi
Whole–genome characterization of chemoresistant ovarian cancer
Nature 2015cited by 1,632position: middledoi
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
British Journal of Cancer 2015cited by 157position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

No co-authors indexed yet.